EPO stays proceedings in certain biotechnology cases

Veröffentlicht am: 24. January, 2017

The European Patent Office has decided to stay all proceedings in examination and opposition cases in which the invention is a plant or animal obtained by an essentially biological process.

biotechnology patent patent protection

The decision was taken following the discussion by EPO member states in the Patent Law Committee of the Administrative Council on the recent Notice of the European Commission related to certain articles in the EU Biopatent Directive (98/44/EC).

Amongst other things, the Commission’s Notice, published on 3 November, considers that according to the EU legislator, plants and animals derived from essentially biological processes should not be considered patentable.

In its practice the EPO applies the Biopatent Directive, which was introduced into the European Patent Convention by decision of the EPO member states in 1999 and which has no explicit provision in relation with plants or animals obtained from such

processes. Should the EPO member states follow the interpretation offered by the European Commission Notice, the EPO will implement their decision.

 

Further information

 

Source: EPO Press Release

Related Posts

20. November 2018

The European Patent Office (EPO) has revoked Bayer AG's controversial Monsanto biopatent, which was intended to protect the breeding of broccoli to facilitate harvesting. It is the first revocation of a biopatent since the introduction of the newly...

read more

Comments

Your opinion counts: What do you think?

Your email address will not be published. Required fields are marked *

Kontakt / Contact
close slider
Um dieses Angebot nutzen zu können, müssen Sie der Speicherung Ihrer personenbezogenen Daten zustimmen. Wir behandeln diese streng vertraulich und verwenden sie nur zur Kontaktaufnahme mit Ihnen. Mehr dazu lesen Sie in unserer Datenschutz-Erklärung.
Das System verwendet Cookies, die uns eine Nutzeranalyse unserer Website ermöglichen.